Number of megakaryocytic progenitors and adhesion molecule expression of stem cells predict platelet engraftment after allogeneic hematopoietic stem cell transplantation

References

• Begemann PGC, Hassan HT, Kroger N, et al. Correlation of time to platelet engraftment with amount of transplanted CD34+ CD41+ cells after allogeneic bone marrow transplantation. J Hematother Stem Cell Res 2002; 11: 321–6
   PubMedGoogle Scholar
• Yasui K, Matsumoto K, Hirayama F, et al. Differences between peripheral blood and cord blood in the kinetics of lineage-restricted hematopoietic cells: implications for delayed platelet recovery following cord blood transplantation. Stem Cells 2003; 21: 143–51
   Google Scholar
• Briggs C, Hart D, Kunka S, et al. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfus Med 2006; 16: 101–9
   PubMed Web of Science ®Google Scholar
• Demirer T, Ilhan O, Arat M, et al. CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation. J Clin Apheresis 2001; 16: 67–73
   Google Scholar
• Kanamaru S, Kawano Y, Watanabe T, et al. Low numbers of megakaryocyte progenitors in grafts of cord blood cells may result in delayed platelet recovery after cord blood cell transplant. Stem Cells 2000; 18: 190–5
   Google Scholar
• Lapidot T, Dar A, Kollet O. How do stem cells find their way home?. Blood 2005; 106: 1901–10
   PubMed Web of Science ®Google Scholar
• Gold J, Valinski HM, Hanks AN, et al. Adhesion receptor expression by CD34+ cells from peripheral blood or bone marrow grafts: correlation with time to engraftment. Exp Hematol 2006; 34: 680–7
   Google Scholar
• Feng R, Shimazaki C, Inaba T, et al. CD34+/CD41a+ cells best predict platelet recovery after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1998; 21: 1217–22
   PubMed Web of Science ®Google Scholar
• Hogge DE, Lambie K, Sutherland HJ, et al. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant. Bone Marrow Transplant 2000; 25: 589–98
   PubMed Web of Science ®Google Scholar
• Ergene U, Cagirgan S, Pehlivan M, et al. Factors influencing engraftment in autologous peripheral hematopoietic stem cell transplantation (PBSCT). Transfus Apher Sci 2007; 36: 23–9
   PubMedGoogle Scholar
• Drayer AL, Smith Sibinga CT, Esselink MT, et al. In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation. Ann Hematol 2002; 81: 192–7
   PubMedGoogle Scholar
• Lowenthal RM, Faberes C, Marit G, et al. Factors influencing haematopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience. Bone Marrow Transplant 1998; 22: 763–70
   PubMed Web of Science ®Google Scholar
• Miyazaki R, Ogata H, Iguchi T, et al. Comparative analyses of megakaryocytes derived from cord blood and bone marrow. Br J Haematol 2000; 108: 602–9
   PubMed Web of Science ®Google Scholar
• Bornstein R, Garcia-Vela J, Gilsanz F, et al. Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin-induced differentiation. Br J Haematol 2001; 114: 458–65
   Google Scholar
• De Boer F, Kessler FL, Netelenbos T, et al. Homing and clonogenic outgrowth of CD34+ peripheral blood stem cells: a role for l-selectin?. Exp Hematol 2002; 30: 590–7
   Google Scholar
• Dercksen MW, Weimar IS, Richel DJ, et al. The value of flow cytometric analysis of platelet glycoprotein expression of CD34+ cells measured under conditions that prevent P-selectin-mediated binding of platelets. Blood 1995; 86: 3771–82
   PubMed Web of Science ®Google Scholar
• Pratt G, Rawstron AC, English AE, et al. Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve. Br J Haematol 2001; 114: 937–43
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Winter JN, Meng Y, Cohen I. Ex vivo expansion of early and late megakaryocyte progenitors. J Hematother Stem Cell Res 2000; 9: 913–21
   PubMedGoogle Scholar
• Drayer AL, Sibinga CT, Blom NR, et al. The in vitro effects of cytokines on expansion and migration of megakaryocyte progenitors. Br J Haematol 2000; 109: 776–84
   PubMed Web of Science ®Google Scholar
• Bruno S, Gunetti M, Gammaitoni L, et al. In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution. Haematologica 2003; 88: 379–87
   PubMed Web of Science ®Google Scholar
• Decaudin D, Vantelon JM, Bourhis JH, et al. Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma. Bone Marrow Transplant 2004; 34: 1089–93
   PubMed Web of Science ®Google Scholar